Creating headroom: can cutting spend on low-value prescriptions fund new drugs?
Drug funding, Low-value prescriptions, market access, NHS, NHSE, patients
0 Comment
Can reducing NHS spending on ‘low-value’ prescriptions help fund new drugs?